Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in Germany, Bioventure Management specializes in investments within the life sciences sector, particularly biotechnology and medical technology. The firm focuses on translating scientific advancements into tangible benefits for society and investors. Their portfolio includes five companies, reflecting a commitment to high-impact innovations.
Bioventure Management invests in economically strong and socially relevant sectors, including biotechnology, genome editing, medical technology, and nutrition. The firm emphasizes a rigorous selection process based on scientific analysis and entrepreneurial experience, aiming for sustainable value creation.
Notable portfolio companies include REPAIRON GmbH, which develops heart tissue from stem cells for cardiology applications; PROVIREX GmbH, focusing on genome editing for HIV treatment; APTARION BIOTECH AG, working on a novel therapy for severe pneumonia in Phase 2; APHAIA PHARMA AG, offering a patented alternative to weight-loss injections; and DIAMONTECH AG, which develops a non-invasive blood glucose measurement technology.
Bioventure Management focuses on exclusive investments in life science innovations that are economically strong and socially relevant, emphasizing high impact and sustainable value creation.
Yes, Bioventure Management often leads investment rounds, particularly in their focus sectors of biotechnology and medical technology.
The firm prefers companies that are developing innovative solutions in biotechnology, medical technology, and cell therapies, with a strong emphasis on scientific validation and market potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.